In the first quarter of 2025, the FDA issued 13 approvals for oncology treatments, covering nine types of cancer...
A session on molecular degraders at SABCS 2024 highlighted an exciting new frontier for SERDs, PROTACs, LYTACs, and biparatopic...
By Vivek Subbiah, MD, Sarah Cannon Research Institute It is both the best of times and a challenging time...
Researchers at the 2024 San Antonio Breast Cancer Symposium discussed considerations for treating and managing of early-onset breast cancer.
When the chemotherapy drug 5-fluorouracil (5-FU) was approved in 1962, there was limited understanding of how it is metabolized...
Studies presented at the 2024 SABCS examined ways to predict responses to treatments for HR-positive, HER2-negative breast cancer.
Data from clinical trials presented at SABCS may help patients with DCIS make informed choices between different management...
What did we learn about cancer in 2024? How did research advance our understanding of cancer? What new approvals...
The Black TNBC Sanctuary is a resource that provides key information and resources specifically for Black patients with TNBC.
Iron can fuel cancer growth in many ways. Can researchers use tumors’ hunger for iron against them?
AACR is waiving membership dues in over 170 countries and territories based on a new cancer research capacity classification...